Strategic insights into pharmacogenomics coverage: a theory-informed SWOT analysis of UAE insurance stakeholders' perspectives.

ABSTRACT:

Background

Pharmacogenomic (PGx) testing improves treatment outcomes by tailoring therapy to a patient's genetic profile. However, PGx implementation faces global challenges, including costs, reimbursement, and regulations. Initial PGx guidelines exist in the United Arab Emirates (UAE), but insurers' perspectives remain understudied. This study explores insurers' views on policies and strategies to expand PGx adoption and overcome implementation barriers.

Methods

This qualitative study used a semi-structured interview design to explore the perspectives of twelve executive and middle management insurance representatives selected through purposive convenience and snowball sampling. Thematic analysis was conducted inductively, supported by comparative analysis, the Institutiona

SUBMITTER: Abbas MO 

PROVIDER: S-EPMC12860024 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature